Apogee Therapeutics
$135.07
30
-$0.01-0.01% Wednesday 20:00
+$0.04+0.03%Wednesday 23:29After hours
Statistics
Day High
135.09
Day Low
135.06
52W High
135.09
52W Low
35.39
Volume
4,970,329
Avg. Volume
2,793,147
Mkt Cap
10.22B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
16NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.22
-1.13
-1.04
-0.95
Expected EPS
-1.154749
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-255.84MNet Income
Analyst Ratings
$135.52Average Price Target
The highest estimate is 140.00.
From 13 ratings within the last 6 months. This is not an investment recommendation.
From 13 ratings within the last 6 months. This is not an investment recommendation.
Buy 8%
Hold 92%
Sell 0%
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
Show more...
CEO
Michael Thomas Henderson
Employees
261
Country
United States
ISIN
US03770N1019
Listings
0 Comments
Share your thoughts
FAQ
What is Apogee Therapeutics stock price today?▼
The current price of APGE is $135.07 USD — it has decreased by -0.01% in the past 24 hours. Watch Apogee Therapeutics stock price performance more closely on the chart.
What is Apogee Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Apogee Therapeutics stocks are traded under the ticker APGE.
Is Apogee Therapeutics stock price growing?▼
APGE stock has risen by +0% compared to the previous week, the month change is a +0.07% rise, over the last year Apogee Therapeutics has showed a +239.12% increase.
What is Apogee Therapeutics market cap?▼
Today Apogee Therapeutics has the market capitalization of 10.22B
When is the next Apogee Therapeutics earnings date?▼
Apogee Therapeutics is going to release the next earnings report on November 16, 2026.
What were Apogee Therapeutics earnings last quarter?▼
APGE earnings for the last quarter are -1.14 USD per share, whereas the estimation was -1.07 USD resulting in a -6.35% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Apogee Therapeutics revenue for the last year?▼
Apogee Therapeutics revenue for the last year amounts to 0 USD.
What is Apogee Therapeutics net income for the last year?▼
APGE net income for the last year is -255.84M USD.
How many employees does Apogee Therapeutics have?▼
As of September 29, 2026, the company has 261 employees.
In which sector is Apogee Therapeutics located?▼
Apogee Therapeutics operates in the Health & Wellness sector.
When did Apogee Therapeutics complete a stock split?▼
The last stock split for Apogee Therapeutics was on January 08, 2008 with a ratio of 1:50.
Where is Apogee Therapeutics headquartered?▼
Apogee Therapeutics is headquartered in SAN FRANCISCO, United States.